NN6 logo

NanoRepro AG Stock Price

XTRA:NN6 Community·€20.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

NN6 Share Price Performance

€1.64
0.10 (6.84%)
€1.64
0.10 (6.84%)
Price €1.64

NN6 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet and fair value.

2 Risks
2 Rewards

NanoRepro AG Key Details

€5.2m

Revenue

€2.1m

Cost of Revenue

€3.1m

Gross Profit

€4.8m

Other Expenses

-€1.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.14
59.31%
-33.04%
0%
View Full Analysis

About NN6

Founded
2006
Employees
23
CEO
Lisa Jungst
WebsiteView website
www.nanorepro.com

NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, such as family planning, and preventive healthcare line products; tests for hospitals and medical practices to detect aids, Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women, including Alphabiol Beauty Elixier for the skin shine based on combination of micronutrients; Alphabiol Fertility for men; Alphabiol Curcumin Elixier mit Curcumin + Vitamin D, an essential nutrient for Vitamin D through online shops and pharmacies. The company was founded in 2006 and is headquartered in Marburg, Germany.

Recent NN6 News & Updates

Recent updates

No updates